Risk Factors for Failure in Double-Plate Tube Surgery for Refractory Glaucoma: 25 Years Surgical Experience

Susana Duch, Carlos A Arciniegas-Perasso, Stefania Piludu, Shirin Djavanmardi, Elena Milla Department of Ophthalmology, Innova Ocular ICO-Barcelona, Barcelona, SpainCorrespondence: Susana DuchInnova Ocular ICO Barcelona, c/Fco Carbonell 42 AT, Barcelona, 08034, SpainTel +34-629370919Email sdt1237654...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Duch S, Arciniegas-Perasso CA, Piludu S, Djavanmardi S, Milla E
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/83a024916dcc48a0a5c75b11a6a45c41
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:83a024916dcc48a0a5c75b11a6a45c41
record_format dspace
spelling oai:doaj.org-article:83a024916dcc48a0a5c75b11a6a45c412021-12-02T14:24:10ZRisk Factors for Failure in Double-Plate Tube Surgery for Refractory Glaucoma: 25 Years Surgical Experience1177-5483https://doaj.org/article/83a024916dcc48a0a5c75b11a6a45c412021-02-01T00:00:00Zhttps://www.dovepress.com/risk-factors-for-failure-in-double-plate-tube-surgery-for-refractory-g-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Susana Duch, Carlos A Arciniegas-Perasso, Stefania Piludu, Shirin Djavanmardi, Elena Milla Department of Ophthalmology, Innova Ocular ICO-Barcelona, Barcelona, SpainCorrespondence: Susana DuchInnova Ocular ICO Barcelona, c/Fco Carbonell 42 AT, Barcelona, 08034, SpainTel +34-629370919Email sdt1237654@gmail.comPurpose: To investigate risk factors associated with success and failure in double-plate tube surgery.Methods: This retrospective case-series observational study included 243 consecutive eyes that underwent anterior-segment double-plate tube surgery from 1990 to 2015. Evaluation of the efficacy of the device was based on the final intraocular pressure (IOP) and the need for anti-glaucoma medication. We also assessed success and failure according to risk factors for trabeculectomy and an early hypertensive phase (HP).Results: Preoperative IOP was 37.3± 13.1 mmHg (mean±SD) with 3.0± 0.7 medications. After a median follow-up of 44.3 months, the mean IOP was 14.6± 6.3 mmHg with 0.4± 1.0 medications. The final IOPs ranged from 6 to 21 mmHg in 87.24% of eyes; however, 25.47% required medication. No risk factors studied were associated with surgical failure. Preoperative IOP, glaucoma type, previous surgery, previous anti-glaucoma drugs, implant type, and HP were associated with partial success (p< 0.05). HP and preoperative use of brimonidine reduced the probability of complete success by 66.9% and 68.2%, respectively (p< 0.05). HP was more likely when chronic preoperative prostaglandin analogues were administered (odds ratio [OR] 4.286; 95% confidence intervals [CI] 1.593– 11.529; P=0.0039) and when the tube was located in the posterior chamber (OR 3.561; 95% CI 1.286– 9.861; P=0.0145).Conclusion: Tube surgery is effective and seems to be independent of the major risk factors for glaucoma surgery. However, previous surgery and some chronic preoperative drugs are related to the need for glaucoma medication to achieve the target pressure.Keywords: glaucoma drainage implants, tube shunt, double-plate Molteno implant, glaucoma surgery, hypertensive phase, refractory glaucomaDuch SArciniegas-Perasso CAPiludu SDjavanmardi SMilla EDove Medical Pressarticleglaucoma drainage implants. tube shuntdouble plate molteno implantglaucoma surgeryhypertensive phaserefractory glaucomaOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 15, Pp 461-472 (2021)
institution DOAJ
collection DOAJ
language EN
topic glaucoma drainage implants. tube shunt
double plate molteno implant
glaucoma surgery
hypertensive phase
refractory glaucoma
Ophthalmology
RE1-994
spellingShingle glaucoma drainage implants. tube shunt
double plate molteno implant
glaucoma surgery
hypertensive phase
refractory glaucoma
Ophthalmology
RE1-994
Duch S
Arciniegas-Perasso CA
Piludu S
Djavanmardi S
Milla E
Risk Factors for Failure in Double-Plate Tube Surgery for Refractory Glaucoma: 25 Years Surgical Experience
description Susana Duch, Carlos A Arciniegas-Perasso, Stefania Piludu, Shirin Djavanmardi, Elena Milla Department of Ophthalmology, Innova Ocular ICO-Barcelona, Barcelona, SpainCorrespondence: Susana DuchInnova Ocular ICO Barcelona, c/Fco Carbonell 42 AT, Barcelona, 08034, SpainTel +34-629370919Email sdt1237654@gmail.comPurpose: To investigate risk factors associated with success and failure in double-plate tube surgery.Methods: This retrospective case-series observational study included 243 consecutive eyes that underwent anterior-segment double-plate tube surgery from 1990 to 2015. Evaluation of the efficacy of the device was based on the final intraocular pressure (IOP) and the need for anti-glaucoma medication. We also assessed success and failure according to risk factors for trabeculectomy and an early hypertensive phase (HP).Results: Preoperative IOP was 37.3± 13.1 mmHg (mean±SD) with 3.0± 0.7 medications. After a median follow-up of 44.3 months, the mean IOP was 14.6± 6.3 mmHg with 0.4± 1.0 medications. The final IOPs ranged from 6 to 21 mmHg in 87.24% of eyes; however, 25.47% required medication. No risk factors studied were associated with surgical failure. Preoperative IOP, glaucoma type, previous surgery, previous anti-glaucoma drugs, implant type, and HP were associated with partial success (p< 0.05). HP and preoperative use of brimonidine reduced the probability of complete success by 66.9% and 68.2%, respectively (p< 0.05). HP was more likely when chronic preoperative prostaglandin analogues were administered (odds ratio [OR] 4.286; 95% confidence intervals [CI] 1.593– 11.529; P=0.0039) and when the tube was located in the posterior chamber (OR 3.561; 95% CI 1.286– 9.861; P=0.0145).Conclusion: Tube surgery is effective and seems to be independent of the major risk factors for glaucoma surgery. However, previous surgery and some chronic preoperative drugs are related to the need for glaucoma medication to achieve the target pressure.Keywords: glaucoma drainage implants, tube shunt, double-plate Molteno implant, glaucoma surgery, hypertensive phase, refractory glaucoma
format article
author Duch S
Arciniegas-Perasso CA
Piludu S
Djavanmardi S
Milla E
author_facet Duch S
Arciniegas-Perasso CA
Piludu S
Djavanmardi S
Milla E
author_sort Duch S
title Risk Factors for Failure in Double-Plate Tube Surgery for Refractory Glaucoma: 25 Years Surgical Experience
title_short Risk Factors for Failure in Double-Plate Tube Surgery for Refractory Glaucoma: 25 Years Surgical Experience
title_full Risk Factors for Failure in Double-Plate Tube Surgery for Refractory Glaucoma: 25 Years Surgical Experience
title_fullStr Risk Factors for Failure in Double-Plate Tube Surgery for Refractory Glaucoma: 25 Years Surgical Experience
title_full_unstemmed Risk Factors for Failure in Double-Plate Tube Surgery for Refractory Glaucoma: 25 Years Surgical Experience
title_sort risk factors for failure in double-plate tube surgery for refractory glaucoma: 25 years surgical experience
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/83a024916dcc48a0a5c75b11a6a45c41
work_keys_str_mv AT duchs riskfactorsforfailureindoubleplatetubesurgeryforrefractoryglaucoma25yearssurgicalexperience
AT arciniegasperassoca riskfactorsforfailureindoubleplatetubesurgeryforrefractoryglaucoma25yearssurgicalexperience
AT piludus riskfactorsforfailureindoubleplatetubesurgeryforrefractoryglaucoma25yearssurgicalexperience
AT djavanmardis riskfactorsforfailureindoubleplatetubesurgeryforrefractoryglaucoma25yearssurgicalexperience
AT millae riskfactorsforfailureindoubleplatetubesurgeryforrefractoryglaucoma25yearssurgicalexperience
_version_ 1718391436798328832